575 related articles for article (PubMed ID: 2893634)
21. Evaluation of the effect on heart rate variability of a beta2-adrenoceptor agonist and antagonist using non-linear scatterplot and sequence methods.
Hanratty CG; Silke B; Riddell JG
Br J Clin Pharmacol; 1999 Feb; 47(2):157-66. PubMed ID: 10190650
[TBL] [Abstract][Full Text] [Related]
22. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
Pringle TH; McNeill AJ; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of single and multiple doses of flusoxolol (Ro 31-1411) in healthy subjects.
Gillies HC; Rogers HJ; Francis RJ; Galloway DB; Humphreys JE
Eur J Clin Pharmacol; 1986; 31(1):113-5. PubMed ID: 2877883
[TBL] [Abstract][Full Text] [Related]
24. Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.
Brodde OE; Schemuth R; Brinkmann M; Wang XL; Daul A; Borchard U
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):130-8. PubMed ID: 2875397
[TBL] [Abstract][Full Text] [Related]
25. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Arnold JM; O'Connor PC; Riddell JG; Harron DW; Shanks RG; McDevitt DG
Br J Clin Pharmacol; 1985 May; 19(5):619-30. PubMed ID: 2860915
[TBL] [Abstract][Full Text] [Related]
26. A comparison of the cardioselectivity of five beta-adrenoceptor blocking drugs.
Pringle TH; Riddell JG; Shanks RG
J Cardiovasc Pharmacol; 1987 Aug; 10(2):228-37. PubMed ID: 2441175
[TBL] [Abstract][Full Text] [Related]
27. Peripheral vascular effects of bufuralol in hypertensive and normal subjects: a comparison with propranolol and pindolol.
Johnston GD; Finch MB; Shanks RG
Eur J Clin Pharmacol; 1986; 30(6):649-52. PubMed ID: 3533562
[TBL] [Abstract][Full Text] [Related]
28. Clinical pharmacology of pindolol.
Aellig WH
Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
[TBL] [Abstract][Full Text] [Related]
29. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
[TBL] [Abstract][Full Text] [Related]
30. Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).
Vukovich RA; Foley JE; Brown B; Willard DA; Buckley M; O'Kelly D; Fitzgerald D; Tormey W; Darragh A
Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):167S-172S. PubMed ID: 37871
[TBL] [Abstract][Full Text] [Related]
31. Does treatment with beta-adrenergic blocking agents cause a decrease in beta 2-adrenoceptor affinity?
Blankesteijn WM; Graafsma SJ; Hectors MP; Olde Riekerink EA; Rodrigues de Miranda JF; Thien T
Eur J Clin Pharmacol; 1992; 42(6):613-8. PubMed ID: 1352497
[TBL] [Abstract][Full Text] [Related]
32. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
[TBL] [Abstract][Full Text] [Related]
33. Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.
Tomlinson B; Cruickshank JM; Hayes Y; Renondin JC; Lui JB; Graham BR; Jones A; Lewis AD; Prichard BN
Br J Clin Pharmacol; 1990 Nov; 30(5):665-72. PubMed ID: 1980200
[TBL] [Abstract][Full Text] [Related]
34. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
Silke B; Guy S; Riddell JG
J Cardiovasc Pharmacol; 1997 Dec; 30(6):817-23. PubMed ID: 9436823
[TBL] [Abstract][Full Text] [Related]
35. Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.
O'Connor PC; Arnold JM; Brown AN; Francis RJ; Finch MB; Galloway DB; Harron DW; McDevitt DG; Shanks RG
Br J Clin Pharmacol; 1985 Mar; 19(3):319-27. PubMed ID: 2859047
[TBL] [Abstract][Full Text] [Related]
36. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Floras JS; Jones JV; Hassan MO; Sleight P
Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
[TBL] [Abstract][Full Text] [Related]
37. Effect of propranolol and pindolol on the up-regulation of lymphocytic beta adrenoceptors during acute submaximal physical exercise. A placebo-controlled double-blind study.
Mäki T; Näveri H; Leinonen H; Sovijärvi A; Lewko B; Härkönen M; Kontula K
J Cardiovasc Pharmacol; 1990 Apr; 15(4):544-51. PubMed ID: 1691382
[TBL] [Abstract][Full Text] [Related]
38. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
Beaulieu G; Grimes D; Muirhead C; Oshiro G
Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394
[TBL] [Abstract][Full Text] [Related]
39. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Haynes JM
Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
[TBL] [Abstract][Full Text] [Related]
40. Heart rate variability effects of an agonist or antagonists of the beta-adrenoceptor assessed with scatterplot and sequence analysis.
Silke B; Riddell JG
Clin Auton Res; 1998 Jun; 8(3):145-53. PubMed ID: 9651664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
